ipps-m: incorporating genomic data into the ipps criteria for mds
Published 11 months ago • 77 plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
2:23
benefits, applicability & uses of the ipss-m in mds
-
4:01
the latest genomic updates in the field of mds
-
1:30
the prognostic value of patient-reported outcomes in mds
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
1:04:28
understanding mds and mpn overlap syndrome
-
25:58
'albumin — when to use in critically ill? ' by dr a d mudalige
-
4:39
imetelstat shows promise in advanced myelofibrosis
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:30
genomics: mds pathology & treatment
-
3:22
performance of the aipss-mds ml model in predicting os & leukemic transformation in cmml
-
1:41
an overview of the mds diagnosis pathway
-
2:01
updates in mds diagnosis and prognosis with the ipss-m: personalized medicine in 2023
-
3:35
real-world validation of the value of the ipss-m for prognostication in patients with mds
-
2:44
implementing machine learning to improve mds prognostication
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
3:10
the role of ngs in mds diagnosis
-
1:26
current and emerging prognostic factors for mds/mpn
-
1:00
how genomic testing has influenced treatment approaches and clinical trial design in mpns